← SynDRA
DERACOXIB
SynDRA canonical compound SYN0001665 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | PTGS2 |
|---|
| Mechanism of action | Cyclooxygenase inhibitor |
|---|
| Indication | osteoarthritis |
|---|
| Disease area | rheumatology |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABCB11
- ALDH1A1
- HDAC6
- SLCO1B1
- SLCO1B3
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CP2C9
- CP2D6
- CP3A4
- ESRRA
- GLI3
- HTT
- NF2L2
- NR1I2
- RARA
Drug classes
- Analgesics
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Antirheumatic Agents
- Cyclooxygenase Inhibitors
- Enzyme Inhibitors
- Peripheral Nervous System Agents
- Sensory System Agents
Cross-references
Synonyms
- Coxiba
- Deramaxx
- Doxidyl
- OstiMax
- Rederox
- NSC-758935
- SC-59046
- NSC 758935
- SC 59046
- VX29JB5XWV
- SC 46
- deracoxibum
- DTXCID2025975
- CHEBI:73032
- OstiMax Chewable
- Deracoxib Chewable
- DOXIDYL Chewable
- RefChem:54945
- Deramaxx Chewable Tablets
- Deracoxib Chewable Tablets
- C17H14F3N3O3S
- SC-046
- MFCD09837763
- Deracoxib [USAN]
- Deram
- Deracoxib (USAN)
- NCGC00095312-01
- CAS-169590-41-4
- Deracoxib [USAN:INN]
- UNII-VX29JB5XWV
- DERACOXIB [INN]
- DERACOXIB [MI]
- Spectrum2_000521
- Spectrum3_001677
- Spectrum4_001227
- Spectrum5_001644
- DERACOXIB [WHO-DD]
- SCHEMBL24645
Look up DERACOXIB in the interactive SynDRA portal →